Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Jacques Kiladjian

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
Critical Reviews in Oncology/Hematology|November 4, 2022
Anemia in myelofibrosis: Current and emerging treatment optionsFrancesco Passamonti, Claire N Harrison, Ruben A Mesa, et al.
Clinical Drug Investigation|November 28, 2012
Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS studyJean-Jacques Kiladjian, Carlos Besses, Martin Griesshammer, et al.
Blood Cancer Journal|July 28, 2021
Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysisLéa Sureau, Corentin Orvain, Jean-Christophe Ianotto, et al.
Blood Advances|January 14, 2022
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibitionNabih Maslah, Emmanuelle Verger, Stéphane Giraudier, et al.
Cancer|February 25, 2023
Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studiesSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Ejhaem|August 21, 2023
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practiceShanti Amé, Fiorenza Barraco, Jean-Christophe Ianotto, et al.
Leukemia Research|December 4, 2012
Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS studyCarlos Besses, Jean-Jacques Kiladjian, Martin Griesshammer, et al.
Annals of Hematology|September 28, 2018
Next-generation sequencing for JAK2 mutation testing: advantages and pitfallsNabih Maslah, Emmanuelle Verger, Marie-Helene Schlageter, et al.
Experimental Hematology|February 16, 2011
Identification of JAK2 mutations in canine primary polycythemiaStephanie Beurlet, Patricia Krief, Arnaud Sansonetti, et al.
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
Critical Reviews in Oncology/Hematology|November 4, 2022
Anemia in myelofibrosis: Current and emerging treatment optionsFrancesco Passamonti, Claire N Harrison, Ruben A Mesa, et al.
Clinical Drug Investigation|November 28, 2012
Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS studyJean-Jacques Kiladjian, Carlos Besses, Martin Griesshammer, et al.
Blood Cancer Journal|July 28, 2021
Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysisLéa Sureau, Corentin Orvain, Jean-Christophe Ianotto, et al.
Blood Advances|January 14, 2022
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibitionNabih Maslah, Emmanuelle Verger, Stéphane Giraudier, et al.
Cancer|February 25, 2023
Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studiesSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Ejhaem|August 21, 2023
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practiceShanti Amé, Fiorenza Barraco, Jean-Christophe Ianotto, et al.
Leukemia Research|December 4, 2012
Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS studyCarlos Besses, Jean-Jacques Kiladjian, Martin Griesshammer, et al.
Annals of Hematology|September 28, 2018
Next-generation sequencing for JAK2 mutation testing: advantages and pitfallsNabih Maslah, Emmanuelle Verger, Marie-Helene Schlageter, et al.
Experimental Hematology|February 16, 2011
Identification of JAK2 mutations in canine primary polycythemiaStephanie Beurlet, Patricia Krief, Arnaud Sansonetti, et al.
Pageof 21